Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon?
Hodgkinson
S J
SJ
The University of New South Wales, Australia.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta